A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
Robyn P.M. Saw, Serigne N. Lo, Georgina V. Long, John F. Thompson, Youngchul Kim, Lilit Karapetyan, Lars Ny, Alexander C.J. van Akkooi, Roger Olofsson Bagge, Jonathan S. Zager